Conference Coverage

Autologous Hematopoietic Stem Cells May Treat Aggressive MS Effectively

Neurology Reviews. 2018 December;26(12):40

 

—Erik Greb

Suggested Reading

Sormani MP, Muraro PA, Saccardi R, Mancardi G. NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugs. Mult Scler. 2017;23(2):201-204.

Pages

Recommended Reading

Dietary sodium still in play as a potential MS risk factor
MDedge Neurology
Virus-Specific T-Cell Infusions May Resolve Progressive Multifocal Leukoencephalopathy
MDedge Neurology
Real-world data reveal long-lasting effects achieved with RRMS treatments
MDedge Neurology
Check for neuromyelitis optica spectrum disorder in suspect HIV patients
MDedge Neurology
Food allergies linked to increased MS relapses, lesions
MDedge Neurology
Integrated analysis suggests cladribine’s safety in MS
MDedge Neurology
Does rituximab delay disability progression in patients with secondary progressive MS?
MDedge Neurology
Nuedexta mainly prescribed for dementia, Parkinson’s
MDedge Neurology
Daclizumab beta may be superior to interferon beta on MS disability progression
MDedge Neurology
Interferon Beta May Not Affect Pregnancy Outcomes in MS
MDedge Neurology